Avignon, FRANCE - February 26th, 2008 - Naturex announces today its participation in the project "New Technologies for Ginseng Agriculture and Product Development", an innovative program oriented to validate several health claims on North American Ginseng. Researches will focus on various medical and health areas, including metabolic syndrome, stress, physical endurance, cardiovascular diseases, immuno-modulation, reproductive health, and neuroprotective and psychiatric disorders.
Ginseng is one of the most widely used medicinal herbs in the world. The two best-selling species are North American ginseng (Panax quinquefolius) and Asian ginseng (Panax ginseng). The research project is leaded by Dr. Edmund Lui from the Schulich School of Medicine and Dentistry, University of Western Ontario. Dr. Lui explained "This is the most extensive project on ginseng ever planned; it involves six Ontario's universities, and key participants from the industry like Naturex, the largest botanical extracts manufacturer in North America. The ultimate objectives of this project are health claims validation and to establish an "umbrella branding" for the Ontario ginseng". The scientific team involved in this project consists of researchers with diverse backgrounds including agriculture, life sciences, biochemistry, social sciences, economics, and marketing.
On January 29th, the Ontario Minister of Research and Innovation, Mr. John Wilkinson, announced that his Government will grant 6.9 million Canadian dollars to Ontario Research Fund as a contribution to this five-year project.
Jacques Dikansky, President and C.E.O. of Naturex, declared "We believe in this project because it is a milestone in the dietary supplement business. For the first time all of the participants will join efforts to create an innovative and scientifically-supported range of North American ginseng derivatives. For this reason, Naturex is proud in supporting this ambitious project”. Naturex will provide its expertise in ginseng extraction and pesticides removal as well as its extensive in-house analytical capabilities (including HPLC, HPLC-MS, PPSL, GC, GC-MS, ICP, NMR, pesticides, and microbiology).
Naturex develops, manufactures and markets natural ingredients for the food, dietary supplement and nutraceutical, pharmaceutical, and cosmetic industries. Headquartered in Avignon, France, the group has an international reach, with over 90% of its sales generated in 30 different countries outside France, 60% of which in North America. Naturex has production facilities in France, Morocco, the United States and Italy, a subsidiary in the United Kingdom, and a representative office in Singapore.